AAAAAA

   
Results: 1-8 |
Results: 8
BENEFITS OF GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER STEM-CELL TRANSFUSION IN INTENSIVE SEQUENTIAL CHEMOTHERAPY FOR BREAST-CANCER
Authors: VIENS P GENRE D PROTIERE C GRAVIS G BERTUCCI F COWEN D CAMERLO J CHABANNON C NOVAKOVITCH G CONTE M FINAUD M MOATTI JP MARANINCHI D
Citation: P. Viens et al., BENEFITS OF GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER STEM-CELL TRANSFUSION IN INTENSIVE SEQUENTIAL CHEMOTHERAPY FOR BREAST-CANCER, European cytokine network, 9(1), 1998, pp. 93-98
DISCORDANCE BETWEEN PHYSICIANS ESTIMATIONS AND BREAST-CANCER PATIENTSSELF-ASSESSMENT OF SIDE-EFFECTS OF CHEMOTHERAPY - AN ISSUE FOR MEASURING THE IMPACT OF ANTICANCER TREATMENTS
Authors: MACQUARTMOULIN G GENRE D BOUSCARY ML CAMERLO J CAPPIELLO M GRAVIS G MARANINCHI D MOATTI JP VIENS P
Citation: G. Macquartmoulin et al., DISCORDANCE BETWEEN PHYSICIANS ESTIMATIONS AND BREAST-CANCER PATIENTSSELF-ASSESSMENT OF SIDE-EFFECTS OF CHEMOTHERAPY - AN ISSUE FOR MEASURING THE IMPACT OF ANTICANCER TREATMENTS, European journal of cancer, 33, 1997, pp. 20-20
ELICITATION OF PREFERENCES AND PATIENTS PARTICIPATION IN THE DECISION-MAKING PROCESS
Authors: PROTIERE C GENRE D COWEN D GRAVIS G CAMERLO J ALZIEU C BERTUCCI F MARANINCHI D MOATTI JP VIENS P
Citation: C. Protiere et al., ELICITATION OF PREFERENCES AND PATIENTS PARTICIPATION IN THE DECISION-MAKING PROCESS, European journal of cancer, 33, 1997, pp. 23-23
COST-QUALITY OF LIFE STUDY IN ADVANCED NO METASTATIC BREAST-CANCER PATIENTS TREATED BY A HIGH-DOSE CHEMOTHERAPY WITH SEQUENTIAL REINFUSION OF BLOOD STEM-CELLS
Authors: MACQUARTMOULIN G BOUSCARY ML PROTIERE C GENRE D MARANINCHI D MOATTI JP VIENS P
Citation: G. Macquartmoulin et al., COST-QUALITY OF LIFE STUDY IN ADVANCED NO METASTATIC BREAST-CANCER PATIENTS TREATED BY A HIGH-DOSE CHEMOTHERAPY WITH SEQUENTIAL REINFUSION OF BLOOD STEM-CELLS, European journal of cancer, 33, 1997, pp. 44-44
HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH STEM-CELL SUPPORT FOR NONMETASTATIC BREAST-CANCER
Authors: VIENS P GRAVIS G GENRE D BERTUCCI F COWEN D CAMERLO J CAPPIELLO MA CONTE M FINAUD M CHABANNON C HOUVENAEGHEL G MARANINCHI D
Citation: P. Viens et al., HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH STEM-CELL SUPPORT FOR NONMETASTATIC BREAST-CANCER, Bone marrow transplantation, 20(3), 1997, pp. 199-203
ADJUVANT CHEMOTHERAPY WITH MITOXANTRONE C YCLOPHOSPHAMIDE AND 5-FLUOROURACIL IN BREAST-CANCER - PATIENTS EXPERIENCE
Authors: GENRE D MACQUARTMOULIN G BOUSCARY ML VIENS P COWEN D COMYN IPY MOATTI JP MARANINCHI D
Citation: D. Genre et al., ADJUVANT CHEMOTHERAPY WITH MITOXANTRONE C YCLOPHOSPHAMIDE AND 5-FLUOROURACIL IN BREAST-CANCER - PATIENTS EXPERIENCE, Bulletin du cancer, 84(3), 1997, pp. 240-246
DISCORDANCE BETWEEN PHYSICIANS ESTIMATIONS AND BREAST-CANCER PATIENTSSELF-ASSESSMENT OF SIDE-EFFECTS OF CHEMOTHERAPY - AN ISSUE FOR QUALITY OF CARE
Authors: MACQUARTMOULIN G VIENS P BOUSCARY ML GENRE D RESBEUT M GRAVIS G CAMERLO J MARANINCHI D MOATTI JP
Citation: G. Macquartmoulin et al., DISCORDANCE BETWEEN PHYSICIANS ESTIMATIONS AND BREAST-CANCER PATIENTSSELF-ASSESSMENT OF SIDE-EFFECTS OF CHEMOTHERAPY - AN ISSUE FOR QUALITY OF CARE, British Journal of Cancer, 76(12), 1997, pp. 1640-1645
LIPOSOMAL-DOXORUBICIN IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA
Authors: POIZOTMARTIN I GIOVANNINI M ROSELLO R VIALLAT JR SAUNIERE JF DALMAS AM GENRE D DHIVER C GASTAUT JA
Citation: I. Poizotmartin et al., LIPOSOMAL-DOXORUBICIN IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA, Journal of clinical oncology, 12(3), 1994, pp. 645-645
Risultati: 1-8 |